General Practice · Daytona Beach, FL
NPI
1538107487
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1435 Dunn Ave Ste 101
Daytona Beach, FL, 32114
Phone (803) 849-8430
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
284 services
Medicare patients, 2024
39
Average age 63
Drug cost, 2024
$5.6M
7,580 prescriptions
Company payments, 2025
$3,668
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hector D Nieves-Vazquez was code 99214 (office e&m - established), 66 times for 32 patients. In total Hector D Nieves-Vazquez billed 284 services in 16 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 66 | 32 | $80.48 | $5,311 |
| 36415 Venipuncture Blood Collection | Office | 38 | 26 | $8.65 | $329 |
By year: 2022 $14K for 260 services; 2023 $9,936 for 183 services; 2024 $10K for 284 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 26 | $8.65 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Hector D Nieves-Vazquez prescribed most often to Medicare patients was Rosuvastatin Calcium, with 381 prescriptions and refills. In total Hector D Nieves-Vazquez wrote 7,580 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 381 | 397 | 50 | $2,297 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 352 | 352 | 49 | $1.3M |
| Lisinopril Generic | 301 | 317 | 33 | $814 |
| Atorvastatin Calcium Generic | 282 | 292 | 34 | $1,378 |
| Gabapentin Generic | 259 | 269 | 36 | $1,866 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 214 | 216 | 24 | $741K |
| Valacyclovir Valacyclovir Hcl | 196 | 196 | 25 | $6,304 |
| Amlodipine Besylate Generic | 162 | 167 | 24 | $513 |
| Metformin Hcl Generic | 161 | 175 | 24 | $507 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 160 | 175 | 26 | $4,608 |
| Tivicay Dolutegravir Sodium | 156 | 160 | 21 | $360K |
| Hydrochlorothiazide Generic | 135 | 135 | 18 | $308 |
| Ozempic Semaglutide | 132 | 166 | 15 | $125K |
| Levothyroxine Sodium Generic | 126 | 130 | 17 | $631 |
| Bupropion Xl Bupropion Hcl | 118 | 118 | 15 | $978 |
Brand drugs: 2,292 claims; generic drugs: 5,262 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hector D Nieves-Vazquez $3,668 ($3,668 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $1,599.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 46 | $1,599 |
| Gilead Sciences, Inc. GILD | 32 | $1,050 |
| Theratechnologies Inc. THTX | 10 | $344 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $295 |
| Merck Sharp & Dohme LLC MRK | 9 | $220 |
| Abbvie Inc. ABBV | 3 | $61.84 |
| EMD Serono, Inc. MRK.DE | 2 | $40.28 |
| Napo Pharmaceuticals Inc | 2 | $38.71 |
| Shield Therapeutics Inc STX.L | 1 | $18.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.